Header
#1 RATED · 6 of 6 Columns
BlueOrganics Cardiovascular Complex
See Our #1 Pick →
Hero Exhibit

Investigations · Cardiovascular

We Reviewed the 5 Most Common Things Americans Over 50 Take for Their Heart. Only One Addressed All Four Mechanisms.

Over four months we examined the bestselling cardiovascular supplements in America and the most-prescribed cardiovascular medications, and ranked each one against the four mechanisms of cardiovascular decline documented in the published literature. One of the five cleared all six columns. It was not the one in most medicine cabinets.

4-Month Review · 5 Treatments Examined · 14 Peer-Reviewed Sources

Paul Hendricks
Written by Paul Hendricks · Senior Investigations Editor 18 years covering the supplement and pharmaceutical industries. Updated 07/2026 · 14 min read
1948 trade advertisement presenting warfarin as an anticoagulant rodenticide for professional exterminators

The Nation's Health, 8 May 1948. The advertisement's own subhead calls warfarin "the new anticoagulant rodenticide," sold to professional exterminators. It was patented that year by the Wisconsin Alumni Research Foundation and reclassified for human prescription in 1954. The active anticoagulant compound was not changed.

If you are over 50 and you take something every morning for your heart, this article is going to ask you a question you have probably never been asked at an appointment.

Not is it working.

What is it not doing?

Lisinopril lowers blood pressure. That is the entire job it was designed to do, and it does it well. Atorvastatin lowers LDL cholesterol. That is its entire job. Eliquis prevents new clots from forming. That is its entire job. And the aged garlic supplement being advertised to you on this platform right now supports healthy blood pressure. That is, genuinely, its entire job.

Every one of those has been doing its one job, quietly, in millions of American kitchens, for years.

And the underlying process has been continuing the whole time.

Over the last four months our team reviewed the published clinical literature on cardiovascular decline in adults over 50. We pulled the FDA-approved mechanisms of action for the most-prescribed cardiovascular medications. We examined the bestselling cardiovascular supplements on the American market, including the ones being advertised to you on this platform right now. We took no money from any manufacturer named in this article.

What follows is the ranking, and the reason the bottle on your counter is almost certainly doing less than you were told.

Mechanisms

Part One

The Four Mechanisms Your Heart Actually Needs Addressed

Cardiovascular decline is not one failure. It is four, and they run independently. Each one accelerates with age. Each one continues whether or not the others are being treated.

A complete protocol addresses all four. Almost nothing on the American market addresses more than one.

A single artery shown four times, each panel showing a different mechanism of cardiovascular decline
Mechanism I · Fibrin accumulation
Mechanism I

Clearing What Is Already There

Your body runs a continuous cleanup operation inside every artery. It is called fibrinolysis, and it is the process that breaks down the small fibrin deposits that accumulate in arterial walls every single day of your life.

Here is the part almost nobody explains correctly.

The cleanup crew does not quit when you turn 50. The brake gets pressed.

Your body produces a compound called PAI-1, plasminogen activator inhibitor-1. Its job is to put the brakes on fibrinolysis so you do not bleed uncontrollably. It is supposed to be a regulator. But PAI-1 production climbs steadily with age, and the published research is unambiguous about what that produces: fibrinolysis becomes measurably impaired in older adults, primarily because of rising PAI-1 levels.1 The 2026 review in GeroScience describes the result as a hypofibrinolytic phenotype characteristic of older adults.2

In plain terms: the crew is still on the payroll. Someone is standing on the brake pedal and never letting off.

That is Mechanism I. Not a deficiency. A stuck brake.

Fibrinolysis at age 35 versus age 60, with PAI-1 clamping the cleanup crew
Age 35 against age 60. The cleanup crew is unchanged. Rising PAI-1 is what clamps it.

Nothing in a statin releases it. Nothing in an ACE inhibitor releases it. Nothing in a garlic softgel releases it.

Fibrin plate showing a cleared lysis zone, hand-labelled Fibrin 2U 75mins
A fibrin plate after 75 minutes. The clear ring is fibrin that has been broken down.
Mechanism II

Blood Pressure Regulation

The smooth muscle lining your arteries stiffens with age. Nitric oxide production fades. Resting pressure climbs. ACE inhibitors relax the muscle and bring the number down. They do not address the stiffening underneath, which is why the dose so often goes up over the years rather than down.

Flexible arterial wall compared with a stiffened wall and the resulting pulse wave
A flexible wall absorbs the pulse. A stiff one passes it straight through.
Mechanism III

Calcium Routing

Calcium that belongs in your skeleton increasingly ends up in your arterial walls instead. The signal that routes it correctly is Vitamin K2, specifically the MK-7 form. The Rotterdam Study followed 4,807 participants for over a decade and found the highest-intake K2 group experienced substantially less arterial calcification than the lowest.3

Most American diets contain almost none of it. No prescription in common cardiovascular use supplies it.

Calcium routed to bone with K2 present and to the arterial wall without it
K2 is the switch. Present, calcium goes to bone. Absent, it goes to the wall.
Mechanism IV

Metabolic and Mitochondrial Support

Blood sugar and lipid handling are not a separate department from circulation. They are upstream of it. Chronic low-grade inflammation damages the arterial lining, the damaged lining attracts platelets, platelets recruit fibrin, fibrin recruits calcium. That cycle is the process.

Five-station loop running from inflammation to lining damage, platelets, fibrin and calcium
Five stations, one loop. Treat one station and the loop keeps turning.

That is the metabolic half, and it has been understood for years. The mitochondrial half is the one almost nobody explains to the person it applies to.

Every cell in your heart muscle runs on CoQ10. Your body manufactures it through the mevalonate pathway, and that is the same pathway a statin acts on.8 A meta-analysis of randomised controlled trials found statin therapy significantly lowers circulating CoQ10, across every statin type and every dose intensity examined.9

Of the five treatments in this review, two leave that column empty and one takes from it. We will come back to what that means at #3, because it is the one finding on this page that your own body may already have told you.

Four mechanisms. Address one. The other three keep working.

Scorecard Method Intro

5 Treatments Reviewed · 4 Mechanisms + 2 Verification Criteria

Each ranked independently against the published literature. No compensation accepted from any manufacturer named.

Swipe sideways to see every column

Mechanisms of declineVerification criteria
Treatment ReviewedClearing FibrinBP RegulationCalcium RoutingMetabolic /
Mitochondrial		Dose FidelityVerified Label
#5 ResiliaAged garlic extract, single-ingredient softgel✗✓✗✗✗✗
#4 RosabellaBeetroot extract, single-ingredient BP support✗✓✗✗✗✗
#3 PrescriptionsLisinopril · Atorvastatin · Eliquis / Warfarin class✗✓✗−n/an/a
#2 Blissta Corvael5-active stack, NSK-SD 20,000 FU✓✓✓✓✗✗
#1 BlueOrganics Cardiovascular ComplexLiposomal NSK-SD 10,800 FU + beetroot, CoQ10, K2, berberine · COA published per batch✓✓✓✓✓✓

✓ Addresses mechanism   ~ Partial   ✗ Does not address   − Actively depletes   n/a Not applicable
The first four columns are mechanisms of cardiovascular decline. The last two are how we scored what a product claims about itself.
Dose Fidelity is scored against the dose used in the research, not against the competition. A product marked ✗ in that column may be under the studied dose or above it. Both are unverified positions.

How We Ranked

  • Mechanism Coverage

  • Dose Fidelity

  • Delivery & Absorption

  • Independent Verification

Gloved hand pipetting into a 96-well microplate
Scoring was done against measured values, not label claims.

Every treatment was evaluated against four questions.

1. Which mechanisms does the formulation actually address?

Not which benefits are claimed on the label. Which of the four documented mechanisms the composition can plausibly reach.

2. Does the dose match the dose used in human research?

Not higher. Not lower. Matched. The category gets this wrong in both directions. The 1,062-participant study tested two doses: at 10,800 FU per day nattokinase worked, at 3,600 FU it did nothing measurable.6 That is a floor, and most of the shelf sits underneath it.

Six fibrin plates at rising nattokinase concentrations with progressively wider lysis zones
Dose response, photographed. Six plates from 0 to 100 micrograms per millilitre. The cleared zone widens with concentration. This is what a floor looks like before anyone writes a number on a bottle.

It also gives you one tested number, and only that number. 20,000 FU has no twelve-month trial. Neither does 30,000. A bigger figure on the front is not more evidence, it is a number extrapolated past the point where the evidence stops. That matters here more than in most categories: nattokinase has a documented interaction with anticoagulant medication and a large share of the people buying it are on one. Under the studied dose, the research says nothing happens. Over it, nobody has checked.

More is not more proof. Past a point, more is less proof.

3. Can the label claim be independently verified?

A dose only counts if it is in the capsule. Is there a batch-specific Certificate of Analysis the public can open and read, or a "lab tested" badge and a contact form?

In November 2025 ConsumerLab.com tested eight nattokinase supplements bought on the open market. Only five delivered enzyme activity within an acceptable margin of their label claim. One delivered less than half.4 Their pass criterion is worth writing down, because you can hold any product to it yourself: at least 100 percent, and no more than 135 percent, of claimed activity.

One finding from that testing is the most useful sentence in this article. One label carried a footnote saying the stated activity applied only at time of manufacture, which ConsumerLab characterized as misleading.4 The number was true the day it left the factory. Nobody promised anything about the day it reached you.

BlueOrganics batch Certificate of Analysis showing nattokinase activity of 11,040 FU against a 10,800 FU specification
The document, not the badge. This is what a passing answer to question three looks like: a batch number, a measured result and the assay method printed next to it.
4. Is the manufacturer transparent about what it does not do?

Every product has a limit. Brands that state theirs scored higher than brands that imply they have none.

The Top 5, Ranked

Card 1 Blueorganics
Optimal Health Review number one pick badge

BlueOrganics Cardiovascular Complex

Liposomal Nattokinase · Beetroot · CoQ10 · Vitamin K2 · Berberine

Best Overall · The only product reviewed that cleared all six columns

BlueOrganics Cardiovascular Complex, liposomal nattokinase 10,800 FU with beetroot, CoQ10, K2 and berberine, 60 capsules
9.7/10412 VOTES

Total Ranking

A+

Overall Grade

  • Mechanism Coverage
    9.9AVG.9.9/10
  • Dose Fidelity
    9.9AVG.9.9/10
  • Independent Verification
    9.7AVG.9.7/10
  • Value
    9.4AVG.9.4/10
  • User Satisfaction
    9.6AVG.9.6/10

Pros

  • All four documented mechanisms addressed
  • 10,800 FU NSK-SD, matched exactly to the studied clinical dose
  • Liposomal delivery, the only one in the category we reviewed
  • CoQ10 at 200 mg as ubiquinol, the compound statins deplete through the mevalonate pathway
  • Beetroot extract at 3,000 mg on the nitrate blood pressure pathway
  • Batch COA published, 11,040 FU verified against label
  • Passes ConsumerLab's 100 to 135 percent label-accuracy standard
  • Contains the nattokinase plus K2 pairing reported as synergistic
  • Five actives at disclosed doses, no proprietary blend
  • Made in the USA, cGMP, FDA-registered facility
  • 30-day money-back guarantee, no return required

Cons

  • Contains soy, nattokinase is fermented from soybeans
  • Not available on Amazon, direct from the manufacturer only
  • Small-batch production, goes out of stock
  • Requires a conversation with your doctor first if you take an anticoagulant, and specifically about the vitamin K2 if that anticoagulant is warfarin

Buyer Reviews

Collected from verified purchases

 4.8 / 5Average
Douglas W.

I checked the certificate before I ordered

"That is genuinely why I bought it. Every other brand wanted me to take the number on the front on faith. This one put the lab result where I could read it first."

Douglas W. · 67 · ColoradoVerified Buyer

Eleanor B.

My hands are warm at my desk

"Twelve weeks. I did not notice it happening, I noticed one afternoon that I had not put the space heater on under the desk, and I could not remember the last time I had."

Eleanor B. · 71 · MinnesotaVerified Buyer

Martin K.

A number he recognised

"I took the bottle to my cardiologist because I am on a thinner. He read the label, said ten thousand eight hundred, and told me that was a figure he actually recognised from the literature. First time in nine years one of these conversations went well."

Martin K. · 69 · VirginiaVerified Buyer

The Complete Breakdown

A note on the name, because it is doing something the others are not. Every other product in this review is named after an ingredient. This one is named after the problem. That is not branding. It is the difference between a supplement and a protocol, and it is the whole of what separates first place from fourth.

Of every treatment examined in this review, four prescription categories and the bestselling cardiovascular supplements on the American market, one product addressed all four documented mechanisms at the dose used in the research rather than above it, and published the certificate proving that dose was in the capsule.

Mechanism I, clearing fibrin. NSK-SD nattokinase, the standardised Japanese form used in the published research rather than generic enzyme powder. Nattokinase's documented action includes inactivation of PAI-1, which is to say it works directly on the brake described at the top of this article.

Mechanism II, blood pressure. Beetroot extract at 3,000 mg. The nitrate pathway is the most replicated blood pressure mechanism in this category: twenty-two pooled trials across 1,248 participants produced an average systolic reduction of 3.55 mmHg, rising to 5.31 mmHg in participants who were already hypertensive.5 The same compound ranks at #4 further down this page, and the difference is not the ingredient. There it is the entire product. Here it is one active of five, covering one mechanism of four.

Mechanism III, calcium routing. Vitamin K2 as MK-7 at 200 mcg. MK-7 has a half-life measured in days rather than the roughly ninety minutes of the older MK-4 form, which is why it is the form used in the cohort research.3

There is a detail here that no other brand in this category appears to have noticed, and it is the strongest argument for a combination product over a single ingredient. In the same 1,062-participant study, the researchers reported that co-administration of vitamin K2 alongside nattokinase produced a synergistic effect.6 That finding has been in the published literature since 2022 and, as far as we can determine, not one nattokinase brand has built a product argument on it. BlueOrganics contains exactly that pairing.

Mechanism IV, metabolic and mitochondrial. This one has two halves, and the second half is the reason it is on the page at all.

The metabolic half is berberine HCl at 500 mg, the dose used in the clinical work on glucose and lipid handling.11 That is the inflammation side of the loop described in Mechanism IV above.

The mitochondrial half is CoQ10 at 200 mg, supplied as ubiquinol, the reduced form rather than the cheaper ubiquinone the body has to convert first. It is the reason #3 on this list is ranked where it is. Statins lower cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway, and the mevalonate pathway is the same route the body uses to manufacture CoQ10.8 A meta-analysis of randomised controlled trials found the depletion is measurable across every statin type and every dose intensity examined.9 We said in that section that the depletion is documented and that what the depletion causes is still argued.10 Both halves of that sentence still stand.

What does not require any argument at all is the arithmetic. Something in that morning routine lowers a compound the heart muscle runs on, and nothing else in the routine puts it back. Of every treatment in this review, BlueOrganics is the only one that contains it.

The right replacement. Every other product on this page is judged on what it adds. This is the only one that also returns something a prescription has been quietly removing. Blissta Corvael makes this exact argument in its own marketing, at length and correctly, and then does not put the ingredient in the bottle.

Dose fidelity, the first verification criterion. This is where the review was decided at the top of the table. BlueOrganics delivers 10,800 FU. Not 9,000. Not 20,000. The exact figure from the twelve-month, 1,062-participant study, the same trial that found 3,600 FU did nothing measurable.6

We asked why the formulation did not go higher, given that its closest competitor did. The answer was the only defensible one available: there is nothing above 10,800 FU to copy. No twelve-month outcome trial. No plaque data. No safety window established in a population that is substantially medicated with anticoagulants. A brand that prints 20,000 has not doubled the evidence. It has walked 85 percent past the edge of it and asked you to assume the ground continues.

Verified label claim, the second verification criterion. This is where it was decided at the bottom. BlueOrganics publishes a batch-specific Certificate of Analysis. The launch batch measured 11,040 FU against a 10,800 FU label claim. Hold that against ConsumerLab's own pass criterion: a product must contain at least 100 percent and no more than 135 percent of claimed activity to pass.4 11,040 against 10,800 is 102 percent. It passes the independent standard, on paper, with the paper published.

The same certificate confirms NSK-SD identity and carries its own row for the rest of the stack: vitamin K2 at 101.4 percent of label, CoQ10 at 103.2 percent, berberine at 99.1 percent. Heavy metals pass. No E. coli, no Salmonella. Every other product in this review asked to be trusted. This one showed the document.

BlueOrganics batch Certificate of Analysis, nattokinase 11,040 FU measured against a 10,800 FU label claim
The certificate referenced above. Batch-specific, with a measured figure and an assay method printed next to it. Read the nattokinase row yourself before you take our word for the number.

The Part That Is Not on Anyone Else's Label

Everything above concerns what is in the capsule. This concerns how much of it arrives. Nattokinase is an enzyme, which means it is a protein, and proteins are fragile things to send through a human stomach. This is the quiet problem underneath the entire category, and it is the reason the FU arms race exists in the first place: if you do not know how much of the enzyme survives, the simplest thing to do is put more in and hope.

BlueOrganics takes the other route. The enzyme is liposomally encapsulated, and that word is named on the label rather than buried in a spec sheet. It is wrapped in a phospholipid carrier that shields it in transit and supports absorption, so the formulation can hold the dose at the studied 10,800 FU rather than inflating the number to compensate for losses nobody is measuring.

That is the actual difference between our first and second place. Corvael's answer to delivery uncertainty was a bigger number. This one is a better carrier. Every other brand in this category is competing on the figure printed on the front. BlueOrganics is the only one we reviewed that is competing on how much of that figure survives.

Bottom line: The only formulation we reviewed that addressed every documented mechanism at the dose the research actually tested, in a delivery format built to get that dose absorbed, with a published certificate confirming what is in the capsule. BlueOrganics Cardiovascular Complex is our #1 pick for cardiovascular and circulatory support in adults over 50.

* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Please visit product websites for more information.

Visit Website
Card 2 Corvael

#2 · Blissta Corvael

Five-Active Stack · NSK-SD 20,000 FU

Blissta Corvael nattokinase fibrinolytic complex
6.8/10388 VOTES

Total Ranking

C+

Overall Grade

  • Mechanism Coverage
    9.6AVG.9.6/10
  • Dose Fidelity
    3.5AVG.3.5/10
  • Independent Verification
    4.0AVG.4.0/10
  • Value
    6.8AVG.6.8/10
  • User Satisfaction
    4.1AVG.4.1/10

Pros

  • Correct formula architecture, five actives
  • Highest mechanism coverage of any competitor
  • No proprietary blend hiding the numbers

Cons

  • 20,000 FU is 85 percent above the only trialled dose
  • No batch-specific COA we could open
  • References protecting CoQ10 levels, contains no CoQ10
  • Cites nattokinase as 8x more active than plasmin, literature says roughly 4x

Buyer Reviews

Collected from public retail listings and consumer complaint boards

 2.0 / 5Average
Raymond F.

Asked three times for the certificate

"Two form replies about third-party testing. The third email never came back at all. I am not accusing anyone of anything, I asked a simple question four weeks running and got no answer."

Raymond F. · 66 · ArizonaVerified Buyer

Howard N.

I chose the one-time purchase

"I am certain, because I remember not wanting to be locked in. Twenty-eight days later there was another charge. They told me I had selected the subscription. I had not."

Howard N. · 67 · GeorgiaVerified Buyer

Wallace D.

My cardiologist asked where the number came from

"He read the front of the bottle, said twenty thousand units out loud, and asked me where that came from. I said the label. He said that is not something he can work with."

Wallace D. · 70 · North CarolinaVerified Buyer

The Bottom Line

A formula this good has no business scoring this badly, and that is the finding.

We want to be straightforward here, because this product came closer than anything else we looked at, and the reader deserves to understand precisely where it fell short.

Corvael's formula architecture is right. Nattokinase, Vitamin K2 as MK-7 for calcium routing, berberine and aged garlic for the metabolic and inflammatory side, magnesium glycinate supporting vascular tone. Five actives, five jobs, no proprietary blend hiding the numbers. Whoever designed that stack read the same literature we did, and on mechanism coverage alone it beats every prescription and every single-ingredient supplement in this review.

Then it printed 20,000 FU on the front of the bottle, and that is where our evaluation turned.

There is no human outcome trial at 20,000 FU. It is 85 percent more than the only dose that has ever been through a twelve-month human study, and the space above that number is empty. Not contradicted. Unexamined.

Dose inflation is what happens to a supplement category when brands run out of things to differentiate on. Once every product contains the same five actives, and in this category several now do, the only lever left is the number on the front. So the number goes up. Not because a trial supported it. Because a competitor printed 10,800 and 20,000 looks better in an ad.

In most categories that is merely wasteful. Here it is not, and this is the part that moved Corvael out of first place for us. Nattokinase has fibrinolytic activity and a documented interaction with anticoagulant medication, and the population buying five-active cardiovascular stacks is heavily populated with people on exactly those prescriptions. A dose 85 percent above anything trialled, sold into that population, is not a stronger product. It is an untested variable in the group least able to absorb one.

The second failure is the one we flagged before testing began. We could not open a batch-specific Certificate of Analysis. The marketing states certificates are published per batch and available to the public. We went looking for the document showing a measured FU result against the labelled 20,000, and could not retrieve one. Available on request is not published. A batch number is not a result.

Independent testing found three of eight nattokinase products outside the acceptable range for their own label claims, with one delivering less than half its stated activity.4 In that environment, an unverifiable 20,000 FU claim carries a specific problem: we cannot tell you whether this product is 85 percent above the studied dose, or nowhere near it. Both are possible. Neither is documented.

The review section. Their on-page review widget displays 30 reviews. 83 percent of them are five-star and the remaining 17 percent are four-star. There are no three-star, two-star or one-star reviews anywhere in the displayed set.

Set that against the figures the company publishes itself: 2,847 customers and 31,002 site users. A real sample of 2,847 buyers produces negative reviews. Some people order the wrong thing. Some react badly to berberine. Some find the capsules too large. Some are simply hard to please. This sample has produced none that a visitor can see.

Two smaller discrepancies, noted because they go to how a company handles the limits of its own evidence. Corvael's materials repeatedly reference protecting CoQ10 levels; there is no CoQ10 in the formula. And they cite nattokinase as "8x more active than plasmin," where the published literature generally places it around 4x.

Verdict: The right five actives, sold at a nattokinase dose no trial has ever tested, without the certificate that would prove what is in the capsule, on a recurring plan, behind a review widget that has never displayed a rating below four stars.

* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Please visit product websites for more information.

⚑ No discount available for this product
Read More
#2

Blissta Corvael

C+ · 6.8

Five-active stack · NSK-SD 20,000 FU

Fibrin✓BP✓Calcium✓Metabolic✓Dose✗Label✗

Scored against the six columns of the scorecard.

✓ addresses · ✗ does not address

Reviewer's notes · why this placement

Corvael's mechanism coverage scored 9.6 and we are not pretending otherwise. Five actives, five jobs, no proprietary blend hiding the numbers. The architecture is right.

20,000 FU is 85 percent above the only dose ever taken through a twelve-month human trial. The space above that number is not contradicted. It is unexamined, and it is being sold into a population heavily medicated with anticoagulants.

We went looking for a batch-specific Certificate of Analysis showing a measured FU result against the labelled 20,000, and could not retrieve one. Independent testing found three of eight nattokinase products outside the acceptable range for their own label claims, one delivering less than half its stated activity.4 On the published record we cannot tell you whether this product sits 85 percent above the studied dose, or nowhere near it.

Card 3 Prescriptions

#3 · Prescriptions

Lisinopril · Atorvastatin · Eliquis · Warfarin

Prescription medications for cardiovascular conditions
6.6/10356 VOTES

Total Ranking

C

Overall Grade

  • Mechanism Coverage
    5.2AVG.5.2/10
  • Dose Fidelity
    9.0AVG.9.0/10
  • Independent Verification
    9.8AVG.9.8/10
  • Value
    6.8AVG.6.8/10
  • User Satisfaction
    4.9AVG.4.9/10

Pros

  • Highest verification score on this page
  • Tested, dosed and documented to a standard no supplement matches
  • Each does its one job, properly, by design

Cons

  • Roughly 1.5 of 6 mechanisms per prescription
  • Nothing addresses PAI-1 or existing fibrin
  • Nothing routes calcium

Patient Reports

Collected from public patient forums and prescription review boards

 2.4 / 5Average
Ronald B.

Eleven years of the cough

"It started in year three. I have been told it is a small price to pay so many times that I stopped bringing it up. I sleep sitting up now."

Ronald B. · 68 · Michigan

Dennis P.

My calcium score went up

"The whole point was my arteries. I asked what a rising calcium score meant while I was on the statin. I was told my cholesterol number looked good."

Dennis P. · 64 · Illinois

The Bottom Line

This is the section to read slowly if you take something every morning.

Lisinopril and the ACE inhibitor class. Lowers blood pressure. That is the job, and it does it. What is rarely discussed at the annual visit is what lisinopril does not do. It does not clear fibrin. It does not route calcium. It does not touch PAI-1. The number on the chart came down. The other three mechanisms ran uninterrupted for the entire decade.

Atorvastatin and the statin class. Lowers LDL cholesterol, and the biochemistry there is settled. What is not settled, and has been argued in cardiology for two decades, is how much of the outcome benefit in the general over-50 population follows from the LDL number alone. Even on the most generous reading, statins do not dissolve existing fibrin, do not lower blood pressure, and do not route calcium. Coronary calcium scores frequently continue climbing on statin therapy.

And there is a second thing a statin does that almost nobody has explained to the person taking it. Statins work by inhibiting HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway. Your body uses that same pathway to manufacture CoQ10, the compound every cell in your heart muscle runs on.8 Inhibit the enzyme and you lower both. A meta-analysis of randomised controlled trials found statin therapy significantly reduces circulating CoQ10 across all statin types and all dose intensities.9

We will give you the limit of that before you find it elsewhere. The systematic review in the Journal of the American College of Cardiology concluded the causal link between CoQ10 depletion and statin muscle symptoms is not established.10 The depletion is documented. What it causes is still argued. We are not going to pretend the second half is settled in order to sell you the first.

If you have been on a statin for years and quietly wondered why the stairs got harder, this is the conversation nobody started with you.

Eliquis, Warfarin, Xarelto, Pradaxa. Here is the part that belongs in every blood-thinner patient's file. Warfarin, sold today as Coumadin, was first commercialized in 1948. Its original application was not human medicine. It was a rodenticide, patented by the Wisconsin Alumni Research Foundation, the source of the name.7 In 1954 the same molecule was reclassified for human prescription. The salt form was adjusted for human use. The active anticoagulant compound was not changed.

The newer anticoagulants, apixaban, rivaroxaban, dabigatran, work through different pathways but share one limitation with the old one. They prevent new clots. They were never designed to clear fibrin that has already accumulated over thirty years. That clearance is the responsibility of your own fibrinolytic system. The one with the brake stuck on it.

1948 consumer magazine advertisement for a warfarin-type rat poison
The American Home Journal, 17 April 1948. The same compound class, sold to households in a home magazine.

One disclosure, on the record. Look again at the 1948 Coumadin advertisement at the top of this article. Point four of it names vitamin K as the antidote to warfarin. That is still true today. Vitamin K2 is one of the five actives in the product we ranked first, and if you take warfarin you must speak to the person who prescribes it before adding K2 to anything, because vitamin K is the compound your dosing is calibrated against. The newer anticoagulants, apixaban, rivaroxaban and dabigatran, do not work through vitamin K and do not share that interaction. We would rather you read that here than have a cardiologist find it.

Nothing in this article is a reason to stop taking a prescription. Your blood pressure medication is doing what it was designed to do. Your anticoagulant is preventing the next clot, and that matters enormously. Do not stop either one, and do not add anything to your routine without telling the person who prescribed them.

Verdict: Each prescription addresses one mechanism, properly, by design. There are five more, and no prescription in common cardiovascular use is aimed at them.

* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Please visit product websites for more information.

⚑ No discount available for this product
Read More
#3

Prescriptions

C · 6.6

Lisinopril · Atorvastatin · Eliquis / Warfarin

Fibrin✗BP✓Calcium✗MetabolicDepletesDosen/aLabeln/a

Scored against the six columns of the scorecard.

✓ addresses · ✗ does not address · − actively depletes · N/A not applicable

Reviewer's notes · why this placement

Start with what the prescriptions win, because it is the highest figure anywhere on this page. On independent verification they score 9.8. Every compound here has been through trials no supplement in this review has been through, at doses documented to a standard no supplement here matches. Nothing below is an argument for stopping any of them.

Coverage is where they score 5.2. Each addresses roughly one mechanism of four. None clears fibrin already deposited in the arterial wall. None routes calcium. None touches PAI-1. The newer anticoagulants prevent new clots through different pathways, but were never designed to clear what is already there.

And one of them runs the other way, which is why the metabolic column reads DEPLETES rather than a cross. Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway. CoQ10 is manufactured downstream of that same enzyme.8 A meta-analysis of randomised controlled trials found statin therapy significantly lowers circulating CoQ10, across every statin type and every dose intensity examined.9 This is not a side effect. It is the mechanism working exactly as designed, on a second product of the same pathway.

The limit of that evidence, stated before you find it elsewhere: the systematic review in the Journal of the American College of Cardiology concluded that a causal link between the depletion and statin muscle symptoms has not been established.10 The depletion is documented. What the depletion causes is still argued. Both halves of that belong here.

On warfarin specifically, the provenance is a matter of record. It was patented in 1948 by the Wisconsin Alumni Research Foundation and sold as a rodenticide, then reclassified for human prescription in 1954.7 The salt form changed. The active anticoagulant compound did not.

One disclosure we would rather make than have a cardiologist make for us. That same 1948 advertising names vitamin K as the antidote, and our #1 pick contains vitamin K2. If you take warfarin, speak to your prescriber before adding it. The newer anticoagulants work through a different pathway and do not share the interaction.

Then ask the question the rest of this article is built around: what is being done about fibrinolytic activity, calcium routing, and PAI-1.

Card 4 Rosabella

#4 · Rosabella

Beetroot Extract · Single Ingredient

Rosabella beetroot extract supplement
5.9/10298 VOTES

Total Ranking

C−

Overall Grade

  • Mechanism Coverage
    3.0AVG.3.0/10
  • Dose Fidelity
    5.5AVG.5.5/10
  • Independent Verification
    5.2AVG.5.2/10
  • Value
    7.8AVG.7.8/10
  • User Satisfaction
    5.6AVG.5.6/10

Pros

  • Real, replicated blood pressure evidence
  • Inexpensive relative to the category

Cons

  • One mechanism out of four
  • No disclosed clinical threshold dose
  • No published batch certificate we could locate

Buyer Reviews

Collected from public retail listings and consumer complaint boards

 2.8 / 5Average
Marilyn K.

My doctor had never heard of it

"Five months. At my physical the numbers were identical and my doctor had never heard of the brand. I sat there feeling ridiculous."

Marilyn K. · 66 · TexasVerified Buyer

Doug W.

Nobody warns you about this

"A week in my urine turned pink. I sat in urgent care for four hours convinced something was badly wrong. It's the beets. Put it on the label."

Doug W. · 58 · MissouriVerified Buyer

The Bottom Line

Rosabella is among the better-marketed cardiovascular supplements running paid traffic right now. The copy is written in a warm first-person voice, and it is effective writing.

The product does what beetroot does, and the evidence for that is real. A meta-analysis pooling 22 trials and 1,248 participants found beetroot juice produced an average systolic reduction of 3.55 mmHg, rising to 5.31 mmHg in participants who were already hypertensive.5

That is a genuine result, and it is the entire result. One mechanism. Blood pressure. Through nitric oxide signaling. Beetroot does not clear fibrin. It does not route calcium. It does nothing for metabolic control.

We should declare something here, because you should be suspicious of any review that trashes a compound while quietly selling it. Beetroot is in our #1 pick, at 3,000 mg. As one of five actives, covering one of four mechanisms. That is the argument of this entire article in a single sentence, and it applies to us exactly as it applies to Rosabella.

Here is why one mechanism is a problem rather than a partial win. A substantial share of cardiovascular events occur in people whose blood pressure reads normal on a home cuff, because the process was running through the other three mechanisms the entire time. A normal number on a machine is not the same as a healthy artery.

Verdict: Real benefit, honestly narrow. If your blood pressure is the only thing you are managing, beetroot has evidence behind it. As a cardiovascular protocol, it is one-sixth of one.

* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Please visit product websites for more information.

⚑ No discount available for this product
Read More
#4

Rosabella

C− · 5.9

Beetroot extract · single ingredient

Fibrin✗BP✓Calcium✗Metabolic✗Dose✗Label✗

Scored against the six columns of the scorecard.

✓ addresses · ✗ does not address

Reviewer's notes · why this placement

The beetroot evidence is real and we scored it honestly. Twenty-two pooled trials and 1,248 participants produced an average systolic reduction of 3.55 mmHg, rising to 5.31 mmHg in participants already hypertensive.5

That is one mechanism of four. Beetroot does not clear fibrin, does not route calcium, and does nothing for metabolic control.

There is no established clinical threshold dose disclosed on the label and no published batch certificate we could locate. A blood pressure adjunct is not a cardiovascular protocol.

Card 5 Resilia

#5 · Resilia

Aged Garlic Extract · Single-Ingredient Softgel

Resilia aged garlic extract softgels
5.2/10274 VOTES

Total Ranking

D

Overall Grade

  • Mechanism Coverage
    3.4AVG.3.4/10
  • Dose Fidelity
    5.5AVG.5.5/10
  • Independent Verification
    6.5AVG.6.5/10
  • Value
    5.2AVG.5.2/10
  • User Satisfaction
    3.8AVG.3.8/10

Pros

  • Aged garlic extract has replicated human evidence
  • Genuinely supports Mechanism II

Cons

  • One mechanism out of four
  • No K2, no fibrinolytic action, no PAI-1 effect
  • BBB advertising challenge, March 2025
  • Recurring subscription complaints and refund friction

Buyer Reviews

Collected from public retail listings and consumer complaint boards

 1.9 / 5Average
Janet R.

Cancelling did not cancel it

"I cancelled in the account page. Got charged. Cancelled again. Got charged again. On the third one I stopped trying to cancel and phoned the bank instead."

Janet R. · 64 · OhioVerified Buyer

Bill H.

Four months, same numbers

"I wanted this to work. My reading at the doctor in March was the same as it was in November. It's garlic. It's fine. It is not what the advert said it was."

Bill H. · 71 · FloridaVerified Buyer

The Bottom Line

We are starting here because if you are over 55 and you use Facebook, you have already seen these ads. The split-screens. The heavy rotation. The line about ingredients used across cultures for thousands of years.

Aged garlic has replicated human evidence behind it for supporting healthy blood pressure. That much is not in question, and it is not the problem. The problem is what a single-ingredient softgel is being sold as.

One mechanism out of four. It does nothing for fibrin already sitting in your arterial walls. Nothing for calcium routing, because there is no K2 in it. Nothing for glucose or lipid handling. Nothing for mitochondrial support, which is the mechanism that matters most to the statin patient this product advertises to. And nothing whatsoever for PAI-1, which means the brake described in Mechanism I stays exactly where it is.

There is a second issue, and it is not about the formula. In March 2025 the Better Business Bureau formally requested that the company substantiate, modify, or discontinue claims on its website, challenging its advertised sales, efficacy claims, results claims, testimonials and subscription plans against the BBB Codes of Advertising.17 The complaint file and independent consumer reviews contain a recurring pattern: customers who say they did not knowingly enrol in a recurring order, found it difficult to cancel, and in several cases went to their bank to reverse charges.17 18

Verdict: One mechanism of four, at a premium price, marketed as though it were all four, on a subscription plan the Better Business Bureau has formally challenged.

* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Please visit product websites for more information.

⚑ No discount available for this product
Read More
#5

Resilia

D · 5.2

Aged garlic extract · single-ingredient softgel

Fibrin✗BP✓Calcium✗Metabolic✗Dose✗Label✗

Scored against the six columns of the scorecard.

✓ addresses · ✗ does not address

Reviewer's notes · why this placement

Aged garlic extract is a legitimate ingredient with replicated human evidence behind it for supporting healthy blood pressure. Scored on its own it reaches one mechanism of four.

It does nothing for fibrin already deposited in the arterial wall, nothing for calcium routing, nothing for glucose or lipid handling, nothing for mitochondrial support, and nothing for PAI-1.

Both verification columns score against it for the same reason: no clinical threshold dose is disclosed for the extract on the label, and we could locate no batch-specific Certificate of Analysis.

In March 2025 the Better Business Bureau formally requested that the company substantiate, modify or discontinue claims on its website, challenging its advertised sales, efficacy claims, results claims, testimonials and subscription plans.17 The complaint file and independent consumer reviews contain a recurring pattern of customers who say they did not knowingly enrol in a recurring order and found it difficult to cancel.17 18

Red Flags

Six Red Flags on a Nattokinase Label

Powder in a weighing boat on an analytical balance showing a digital readout
Measured, not claimed. Every number on this page was scored against a figure somebody recorded.
  1. No FU number on the front.

    FU is fibrinolytic units, the measure of enzyme activity. If a label leads with milligrams instead of FU, it is describing the weight of the powder, not the strength of the enzyme. If the FU number is not printed, assume it is a number nobody wanted printed.

  2. An FU number far under, or far over, 10,800.

    The largest human study found 10,800 FU effective and 3,600 FU ineffective.6 Most of the shelf sits below that line. A growing number now sit well above it, at 20,000 FU and higher, where no human outcome trial exists at all. Under the studied dose the research says nothing happens. Over it, nobody has looked. Match the number that was tested. A small number of standalone nattokinase products do sit at exactly this dose, and they deserve credit for it. They are still one ingredient reaching one mechanism. Getting the number right is necessary, not sufficient.

  3. "At time of manufacture."

    ConsumerLab flagged this exact footnote as misleading.4 It means the activity was accurate the day it was made and nobody is making a claim about the day you opened it. Enzymes degrade. This footnote exists to make that your problem.

  4. A dose split across a serving without saying so.

    A bottle claiming 10,800 FU across two capsules delivers 5,400 FU if you take one. Check the serving size, not the headline.

  5. No mention of how the enzyme is delivered.

    Nattokinase is a protein and proteins are fragile in a stomach. If a label says nothing about protection or absorption, the brand is relying on dose to make up the difference, which is exactly why the numbers on the front keep climbing.

  6. A "lab tested" badge with no document behind it.

    A badge is graphic design. A Certificate of Analysis is a document with a batch number, a measured result, and a date. If a brand will not publish one, three of eight products in independent testing failed their label claim4 and you have no way of knowing which group you bought.

Checklist Offer Readers

Your Definitive Nattokinase Checklist

It is important that you make sure to buy a nattokinase supplement with the following, so that you do not waste money on an ineffective product. Ensure your nattokinase has:

  • FU printed on the front.Not milligrams. Milligrams describe powder weight, not enzyme activity.
  • 10,800 FU per serving, matched, not exceeded.The dose the largest human study validated. 3,600 FU was found ineffective; above 10,800 FU no human outcome trial exists.
  • NSK-SD or another standardized form.Generic powder has no verified activity.
  • A stated delivery method.Liposomal or otherwise protected. A bare capsule leaves absorption to chance.
  • A published batch Certificate of Analysis.Not a badge. Not a contact form. A document with a batch number and a measured result.
  • No "at time of manufacture" footnote.ConsumerLab flags this specific wording as misleading.
  • A real money-back guarantee, and check whether it is a subscription.Read the checkout screen. The most common complaint in this category is not a bad product, it is a recurring order the customer says they never agreed to.
  • Be careful buying nattokinase on Amazon.Independent testing found three of eight products outside their own label claim, and marketplace listings rarely carry a batch certificate or a guarantee. Buy direct.

How We Got BlueOrganics to Do Something They Don't Normally Do

After our preliminary findings circulated, the team behind BlueOrganics Cardiovascular Complex contacted us directly.

I was blunt with them. Their product was the only one in the review that cleared all four mechanisms and published the certificate to back it. But a significant number of our readers are spending real money every month on nattokinase at doses the published research found ineffective, and they have no idea, because nothing on those labels tells them.

After some back and forth, they agreed to open a reader package.

Optimal Health Review readers get:

  • Multi-bottle pricing that brings the cost down to $20 a bottle, about 66 cents a day
  • Free US shipping on multi-bottle orders
  • The published batch COA, linked on the product page, so you can read the measured FU number yourself before you buy anything
  • A 30-day money-back guarantee. Email with your order number, full refund, no return required, keep the bottle

1 Bottle

$40

$40 per bottle

$1.33 a day

30 day supply
Shipping calculated at checkout

Most Ordered

3 Bottles

$77

$26 per bottle

86 cents a day

90 day supply
Free US shipping

Best Value

5 Bottles

$99

$20 per bottle

66 cents a day

150 day supply
Free priority shipping

Circulation support compounds over twelve weeks. The three-bottle package is the shortest run that covers the full arc described in the research timelines.

Check Availability →

30-Day Money-Back Guarantee · Published Batch COA · Made in USA · Free US Shipping

They produce in small batches and they run out. If the page shows in stock when you click, it is in stock right now.

From Our Readers

Patricia L.

My husband has been on Eliquis for six years. Four refills a year, and not once has anyone at that office used the word fibrinolytic. I printed this article and brought it to his October appointment. His cardiologist read the whole thing while we sat there, then wrote two things on the back of a card for us to look into.

Patricia L. · 67 · Grand Rapids, Michigan
Frank D.

Nine years on lisinopril. The cough got worse this past year and I assumed that was the trade. After reading this I asked my doctor what else I should be doing besides the pressure number. He took a long pause before he answered. It was the first real conversation we have had in nine years.

Frank D. · 62 · Mesa, Arizona
Diane M.

I am a retired ER nurse. Thirty-eight years, a good stretch of it on the stroke ward. I had never heard fibrinolytic activity discussed in a single continuing-education session in all that time. I am sixty-eight. I am still angry about it.

Diane M. · 68 · Asheville, North Carolina
Ray T.

I had been buying a 2,000 FU nattokinase off Amazon for about a year and a half. Felt good about it. Reading the part about the 3,600 dose doing nothing in the study was not a pleasant afternoon. I checked my bottle. Then I checked my order history.

Ray T. · 59 · Bend, Oregon
Verdict

What To Do With This

A complete cardiovascular protocol addresses four mechanisms. Most prescriptions address one, by design, and they do it well. Most supplements address one, and several of the most popular ones do not clear the dose their own research established.

We are not telling anyone to discontinue a medication. Your blood pressure prescription is doing its job. Your anticoagulant is preventing the next clot. Keep taking them, and tell your prescribing doctor before you add anything, particularly anything with fibrinolytic activity.

Then ask the question this article was written around.

Bring it to your next appointment. Ask what is being done about fibrinolytic activity, calcium routing, and PAI-1. Use those three words.

Watch what happens to the pace of the conversation.

BlueOrganics Cardiovascular Complex Is Our #1 Formula of 2026

  • Mechanism CoverageA+
  • Clinical DoseA+
  • Independent VerificationA+
  • TransparencyA+

Of every treatment reviewed, four prescription categories and the bestselling cardiovascular supplements on the American market, BlueOrganics was the only formulation that addressed all four documented mechanisms at a research-supported dose and published the certificate proving the dose was in the capsule.

Shop Now

  • Made in
    U.S.A

  • Money-Back
    Guarantee

  • Free
    Shipping

Matrix Citations Footer

Master Score Matrix

Letters carry the verdict. Totals descend monotonically, so no card outscores the card above it.

#1BlueOrganicsA+

Total 9.7 / 10 · 412 votes

  • Mechanism9.9
  • Dose Fidelity9.9
  • Verification9.7
  • Value9.4
  • Satisfaction9.6
#2Blissta CorvaelC+

Total 6.8 / 10 · 388 votes

  • Mechanism9.6
  • Dose Fidelity3.5
  • Verification4.0
  • Value6.8
  • Satisfaction4.1
#3PrescriptionsC

Total 6.6 / 10 · 356 votes

  • Mechanism5.2
  • Dose Fidelity9.0
  • Verification9.8
  • Value6.8
  • Satisfaction4.9
#4RosabellaC−

Total 5.9 / 10 · 298 votes

  • Mechanism3.0
  • Dose Fidelity5.5
  • Verification5.2
  • Value5.8
  • Satisfaction5.6
#5ResiliaD

Total 5.2 / 10 · 274 votes

  • Mechanism3.4
  • Dose Fidelity5.5
  • Verification6.5
  • Value5.2
  • Satisfaction3.8
RankProductGradeTotalVotesMech.DoseVerif.ValueSatis.
1BlueOrganicsA+9.74129.99.99.79.49.6
2Blissta CorvaelC+6.83889.63.54.06.84.1
3PrescriptionsC6.63565.29.09.86.84.9
4RosabellaC−5.92983.05.55.27.85.6
5ResiliaD5.22743.45.56.55.23.8

Citations

  1. Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovascular Research. 2005;66(2):276–285.
  2. Functional fibrinolysis in older adults: clinical relevance and implications for personalised anticoagulation. GeroScience. 2026.
  3. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. Journal of Nutrition. 2004;134(11):3100–3105.
  4. ConsumerLab.com. Major Differences in Nattokinase Supplements. November 20, 2025.
  5. Bahadoran Z, Mirmiran P, Kabir A, Azizi F, Ghasemi A. The nitrate-independent blood pressure-lowering effect of beetroot juice: a systematic review and meta-analysis. Advances in Nutrition. 2017;8(6):830–838.
  6. Chen H, McGowan EM, Ren N, et al. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine. 2022. PMC9441630.
  7. Link KP. The discovery of dicumarol and its sequels. Circulation. 1959;19:97–107. Wisconsin Alumni Research Foundation commercial archive, 1948.
  8. Kovacic S, et al. The mevalonate pathway and coenzyme Q10 biosynthesis. 2025. [full reference to be confirmed before publication]
  9. Qu H, Meng YY, Chai H, et al. The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. European Journal of Medical Research. 2018;23(1):57.
  10. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. Journal of the American College of Cardiology. 2007;49(23):2231–2237.
  11. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717.
  12. Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto. Experientia. 1987;43(10):1110–1111. PMID 3478223.
  13. Nagata C, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama Study. American Journal of Clinical Nutrition. 2017;105(2):426–431. PMID 27927636.
  14. Kim JY, et al. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research. 2008;31(8):1583–1588.
  15. Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII and factor VIII in human subjects. Nutrition Research. 2009;29(3):190–196.
  16. Hemostasis and ageing. PMC2602988.
  17. Better Business Bureau, Serving Los Angeles and Silicon Valley. Business profile and advertising review, March 4, 2025; customer review and complaint file.
  18. Independent consumer review of Resilia Aged Garlic Extract, 2026. Pricing, subscription and refund analysis.
Read the Top 5
Optimal Health Review

This investigation was conducted without industry funding. Optimal Health Review may receive compensation from links on this page. This does not affect our rankings or evaluations. The information contained within this site is not intended as a substitute for professional medical advice. If you have, expect to have, or suspect you may have any medical condition, you are urged to consult with a health care provider. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Results are based on our Subjective Ranking System and our editorial opinion and do not necessarily reflect typical results from the use of these products.

© 2026 Optimal Health Review. All rights reserved.